Cara Therapeutics Stock Price (NASDAQ:CARA)

Add to My Stocks
$16.59 $0.27 (1.6%) CARA stock closing price Jun 22, 2018 (Closing)
Prev Close* : $16.86
Market Cap:
$542.49M
Day Low: $16.54
52 Week Low: $11.11
Open: $16.88
Volume: -
Day High: $17.05
52 Week High: $28.50
Dividend:
0.00

Cara Therapeutics Stock Articles & Video

more news on CARA stock

Cara Therapeutics News - From Partners

Cara Therapeutics to Present Data at Kidney Week 2017   by Globe Newswire on Oct 16, 2017

CARA Stockcharts

View CARA PE ratio, PS ratio stocks charts and compare with peers.
CARA Chart
Note: Compare Cara Therapeutics stock price history with the index and industry peers.

Cara Therapeutics Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Cara Therapeutics Returns

ROE
(return on equity)
-67%

Cara Therapeutics Financial Ratios

Asset Turnover
0
Receivables Turnover
0
Debt to Equity
0
Dividend Yield
-999.0000

CARA Industry Peers

Company Price Change (%)
Cascade Corp (CASC)10.020 (0%)
Ac Immune Sa (ACIU)9.410.21 (2.28%)
Pacira Pharma (PCRX)33.750.5 (1.46%)
Pfizer (PFE)36.510.21 (0.58%)
Nektar Therapeutics (NKTR)52.853.01 (5.39%)
Johnson & Johnson (JNJ)122.841.39 (1.14%)
Cumberland Pharma (CPIX)6.110.11 (1.83%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Nymox Pharmaceutical (NYMX)3.890.64 (19.69%)
Vital Therapies (VTL)6.50.7 (12.07%)
AVID BIOSERVICS (CDMO)3.530.26 (7.95%)
MiMedx (MDXG)5.980.39 (6.98%)
BioDelivery Sciences (BDSI)3.10.2 (6.9%)
Arbutus Biopharma (ABUS)6.80.43 (6.75%)
Sorrento Therapeutics (SRNE)6.550.4 (6.5%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018
CompanyPriceChange (%)
Bluebird Bio (BLUE)168.918.45 (9.85%)
Uniquire (QURE)36.183.32 (8.41%)
GTx (GTXI)17.31.19 (6.44%)
Sarepta Therapeutics (SRPT)140.339.32 (6.23%)
Amicus Therapeutics (FOLD)15.810.7 (4.24%)
Amarin (AMRN)2.880.12 (4%)
Compugen (CGEN)3.650.15 (3.95%)
Top losers from Medical-Biomed-Genetics industry
* As of Jun 23, 2018

Cara Therapeutics Inc Stock News - Partner Headlines

Cara Therapeutics Financial Statements

income statement20172016201520142013
Net Sales or Revenues--3.8M3.17M11.96M
Net Income-58.12M-57.28M-24.69M-17.74M-3.96M
Total Operating Expense60.39M58.48M28.99M21.24M12.19M
View Cara Therapeutics income statement
balance sheet20172016201520142013
Total Assets97M63.82M110.89M55.93M18.08M
Total Liabilities10.22M13.1M5.85M4.27M6.57M
Shareholders Equity86.78M50.72M105.04M51.66M11.51M
View Cara Therapeutics balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-3.04M5.98M--1.78M2.43M
Net Cash from (used by) Operating Activities-54.82M-47.38M-21.47M-17.64M2.82M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.71M-0.02M-0.04M-0.01M
View Cara Therapeutics cash flow statement

Cara Therapeutics Stock Message Board

An investor needs to spend $16.59 to buy CARA stock, as the closing Cara Therapeutics stock price is $16.59. Stock price or share price can be used to find the total market value of a company. Cara Therapeutics market cap stands at $542.49M as of Jun 22, 2018. Cara Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy CARA stock than sell it, then Cara Therapeutics stock price goes up. Conversely, if more investors wanted to sell CARA stock than buy it, there would be greater supply than demand, and the stock price would fall. 1,055,845 CARA shares were traded yesterday, and Cara Therapeutics stock chart shows that the CARA stock quote hit a day high of $17.05 and day low of $16.54. Cara Therapeutics paid 0.00 stock dividends to its shareholders during last quarter. Cara Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.